Stockreport

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, annou [Read more]